Abstract Cancer and cardiovascular diseases are the leading causes of mortality worldwide. As these diseases share common metabolic pathways, patients with cancer are currently seen as having subclinical alterations with great potential for developing cardiovascular diseases (and vice versa). This tenuous interrelationship has led to the emergence of cardio-oncology (CO) as an area of study and discussion, with a major impact on the management of these cases. In clinical practice, CO is dominated by the dilemma of how to best […]

In recent decades, advances in cancer treatment have led to a significantly increased survival rate for several types of cancer. On the other hand, cancer survival increases patients’ vulnerability to cardiovascular complications induced by potentially cardiotoxic cancer therapy., Cardiovascular diseases are currently recognized as a main cause of morbidity and mortality in cancer survivors depending on the type of therapeutic approach used, patient age, and the presence of preexisting cardiovascular risk factors. Due to the high incidence of breast cancer […]